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Abstract 
Meningiomas are slow-growing intracranial/intraspinal tumours, with a wide range of 
histopathological variants. The more aggressive atypical and malignant types can 
disseminate via the venous system, lymphatics or cerebrospinal fluid, with the lungs and 
pleura being the most common site of extracranial metastasis. We look at a 68-year-old 
woman presenting with abdominal pain, who had previously been treated for an 
intracranial meningioma with a ventriculo-peritoneal shunt in situ. Investigation 
revealed a lesion in segment 4 of the liver with the shunt tip being in close proximity. 
Biopsy was consistent with metastatic meningioma. A liver resection was subsequently 
performed. We postulate that this is the first reported case of dissemination of an 
intracranial meningioma via cerebrospinal fluid by means of a ventriculo-peritoneal 
shunt. 
Case Report 
A 61-year-old lady presented with headaches and was subsequently diagnosed with a cerebral 
atypical meningioma on cross-sectional imaging. She underwent a craniotomy and resection, and 
further resections for recurrence 2 and 4 years later. During this last operation a ventriculo-peritoneal 
(VP) shunt was inserted at the time of resection. Three years later during routine follow-up, a further 
small recurrence was detected, located around the region of the shunt, which was treated with external 
beam radiotherapy. Following therapy she was living independently with no neurological functional 
deficit. Follow-up cross-sectional imaging revealed no residual disease. She had hypothyroidism but 
was otherwise fit and well. At the age of 68 years she presented to a local hospital with a history of 
right-sided abdominal pain and nausea. She also described loss of appetite, mild weight loss, and a short  
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history of altered bowel habit which swiftly resolved. Clinical examination revealed a right upper 
quadrant mass. 
At the time of presentation her serum liver function tests and coagulation studies were normal. 
Hepatitis serology and autoantibody screening were negative. An ultrasound scan confirmed the 
presence of a large irregular mass in the liver. A staging computed tomography scan was then 
performed which found an ill-defined and heterogeneous mass in segment 4b of the liver with multiple 
incidental cysts. A magnetic resonance imaging scan demonstrated a 7.6 × 8.3 × 6.6 cm lobulated lesion 
inferiorly in segment 4 abutting but not invading the gallbladder and extending to at least the border of 
segment 5. This demonstrated a heterogeneous signal, slightly increased in T2. Interestingly 
post-gandolium there was no marked hypervascularity demonstrated. This lesion was slightly distorting 
the liver capsule. The spleen was of normal size and no ascites was seen. The VP shunt was also noted to 
be in very close proximity to the lesion. The liver was otherwise normal. These cross-sectional imaging 
findings of a solitary large hypovascular liver lesion excluded a cyst, haemangioma or focal nodular 
hyperplasia. They did not represent typical appearances of a liver primary cancer and hence the lesion 
was deemed indeterminate.  
A percutaneous liver biopsy revealed a partly necrotic tumour composed of small groups and strands 
of medium-sized cells set in a collagenous stroma. The tumour cells showed oval, monotonous nuclei 
with homogenous chromatin. Occasional intranuclear inclusions were seen but no mitoses were 
recognised in the very small amount of viable tumour present. Immunohistochemically the tumour 
showed strong, diffuse expression for vimentin and strong staining for epithelial membrane antigen in a 
proportion of cells, an immunophenotype typical for meningioma. There was only very focal positivity 
for cytokeratin and the tumour cells were negative for GFAP, S100 and leucocyte common antigen 
excluding carcinoma, melanoma, neural tumours and lymphoma. 
The appearances of the tumour in the diagnostic liver core biopsy were compared with those of the 
previously resected recurrent WHO grade 2 meningioma and the features in both specimens were 
similar. In particular, the latest recurrence displayed a similar patternless growth with focal necrosis. It 
also showed a high mitotic rate of 17 per 10 high power fields just falling short of a grade 3 anaplastic 
meningioma. The liver biopsy was therefore consistent with metastatic meningioma. 
The patient was referred to the regional Hepato-Pancreatico-Biliary centre where the cross-sectional 
imaging and histology were reviewed and discussed in the multi-disciplinary team. Following patient 
consultation and satisfactory cardiopulmonary exercise testing, a segment 4b and 5 liver resection was 
performed. Intraoperative ultrasound examination was used to demarcate the margins of the tumour 
which were well separated from the right and left vascular inflow. A cholecystectomy was performed 
along with division of omental adhesions. Blood loss was measured as 450 ml. 
The liver resection specimen weighed 800 g and contained an nonencapsulated, multinodular, 
cream-coloured, rubbery tumour measuring 123 mm in greatest dimension, occupying segment 4b and 
5 almost entirely (fig. 1). Histology confirmed a highly cellular tumour with a patternless appearance 
composed of round to elongated cells with ovoid nuclei with focal nuclear vacuoles (fig. 2). The tumour 
showed large areas of necrosis and up to 21 mitoses per 10 high power fields. In view of the mitotic 
count of >20/10 high power fields the appearances were classified as metastatic anaplastic/malignant 
meningioma, likely transferred through the VP shunt. The tumour margin was >10 mm. 
Postoperatively a bile leak was detected. This was managed initially with continued HDU care, 
antibiotics, and a percutaneous abdominal drain. Subsequently two ERCP procedures were needed to 
achieve adequate biliary drainage by placement of a plastic biliary stent placement into the left hepatic 
duct. The patient made a good recovery and was discharged home 14 days postoperatively. 
Discussion 
Meningiomas are slow-growing neoplasms that make up 14–19% of all primary 
intracranial and intraspinal tumours [1]. The WHO have classified 15 histopathological 
variants of meningioma [2]. Of these subtypes meningiothelial, fibrous and transitional 
are the most common (table 1). 
Most meningiomas are benign, however WHO grade 2 and 3 meningiomas have less 
favourable outcomes. Malignant progression is a continuum of increasing atypia. WHO  
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grade 2 and 3 are determined by either a particular histological subtype or by a 
combination of morphological features. Chordoid and clear cell meningioma are 
automatically classified as WHO grade 2 whereas papillary and rhabdoid meningioma 
correspond to WHO grade 3. According to the WHO classification morphological criteria 
for an atypical meningioma are either more than 3 mitoses/10 high power fields [3] or at 
least three of the following features: increased cellularity, small cells with a high 
nuclear:cytoplasmic ratio, prominent nucleoli, uninterrupted patternless or sheet-like 
growth and foci of necrosis. Anaplastic/malignant meningioma shows obviously 
malignant cytology and/or >20 mitoses/10 high power fields [4]. The anaplastic type is the 
most aggressive, with mean overall survival for anaplastic meningiomas being 3.3 years as 
opposed to 11.9 years for atypical meningiomas [5]. 
The occurrence of distant metastasis from a benign meningioma is reported to be rare, 
being estimated at around 0.1% [6]. This occurrence however is significantly higher in 
atypical and malignant cases, being 5 and 30% respectively [7, 8]. The proposed method 
of dissemination is via the venous system, lymphatics or cerebrospinal fluid (CSF). Spread 
to the lymphatic system is postulated to occur as the tumour spreads in the skull and 
scalp, or to the lymphatics around the cranial nerves, for instance in the cavernous sinus 
[9]. Surgical resection allows seeded cells to access the blood and lymphatic system [9], 
however the more common reported route of metastasis is via invasion of the dural 
venous sinuses and cranial veins, with resultant spread into the pulmonary circulation, 
azygous and hemiazygous systems and vertebral venous plexus [10, 11]. This would 
account for the majority of sites for extracranial metastasis, most commonly being the 
lung and pleura (60%), and in order of decreasing frequency: liver, long bones, vertebrae, 
ribs, pleura, mediastinum, and lymph nodes [12, 13]. 
Meningiomas arise from the arachnoid cap cells and thus are invariably in contact with 
CSF. Seeding through CSF pathways however is reported to be rare [14]. What makes our 
case particularly unique is the fact that there is no previously reported case in the 
literature regarding spread in CSF via a VP shunt, into the abdominal cavity. Furthermore 
there are very few reported cases of metastasis to the liver. Figueroa et al. reported on a 
case of metastasising transitional meningioma, spreading initially to the lungs and then to 
the liver [15]. 
Interestingly, and certainly worth considering following surgical resection, is the risk of 
iatrogenic metastasis. Skin metastasis localised around the scar of the resection incision 
has been reported in five cases: one in the temporal muscle [16], one in the abdominal 
wall [17], and three in the scalp [18–20]. The first case was a transitional meningioma, 
whilst the latter three were atypical or anaplastic meningiomas. In view of this a thorough 
operative field washout and frequent changing of surgical tools has been recommended 
[19]. 
Due to the slow-growing nature of metastases and their good prognosis after resection, 
surgery is the recommended treatment for meningiomas. Radiotherapy is ineffective as a 
primary treatment modality; however as an adjuvant it decreases local recurrence and 
time to recurrence after complete or subtotal resection [21]. 
Conclusion 
We believe this to be the first reported case of dissemination of an intracranial 
meningioma via CSF by means of a VP shunt. Whilst spread by the more commonly 
postulated venous route could not be entirely excluded, in view of the reported recurrence  
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of the intracranial meningioma at the shunt site and the close proximity of the shunt to 
the liver lesion, it appears very likely that the spread occurred via the VP shunt. This case 
also demonstrates the importance of considering the possibility of metastasis in a patient 
with a liver lesion and past history of meningioma. We recommend early referral to the 
local hepato-pancreatico-biliary centre, and furthermore, given the reported risks of 
cutaneous seeding [16–20], we would strongly advise against percutaneous liver biopsy in 
a patient with a potentially resectable tumour. 
 
 
 
Table 1. WHO 2000 classification of meningiomas [2] 
WHO grade 1 
Benign, 90% 
WHO grade 2 
Atypical, 7% 
WHO grade 3 
Malignant, 2% 
Meningiothelial meningioma  Chordoid meningioma  Papillary meningioma 
Fibrous (fibroblastic) meningioma  Clear cell meningioma  Rhabdoid meningioma 
Transitional (mixed) meningioma  Atypical meningioma  Anaplastic meningioma 
Psammomatous meningioma     
Angiomatous meningioma     
Microcystic meningioma     
Secretory meningioma     
Lymphoplasmacyte-rich meningioma     
Metaplastic meningioma     
 
 
 
 
Fig. 1. Macroscopic specimen of 123 mm tumour occupying liver segments 4b and 5 almost entirely. 
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Fig. 2. Microscopic specimen of highly cellular tumour with a patternless appearance. 
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